Skip to main content
Portland Press Open Access logoLink to Portland Press Open Access
. 2021 Jun 8;49(3):1065–1074. doi: 10.1042/BST20200175

Evolutionary crossroads of cell signaling: PP1 and PP2A substrate sites in intrinsically disordered regions

Bernhard Hoermann 1,2,, Maja Köhn 1,2,
PMCID: PMC8286827  PMID: 34100859

Abstract

Phosphorylation of the hydroxyl group of the amino acids serine and threonine is among the most prevalent post-translational modifications in mammalian cells. Phospho-serine (pSer) and -threonine (pThr) represent a central cornerstone in the cell's toolbox for adaptation to signal input. The true power for the fast modulation of the regulatory pSer/pThr sites arises from the timely attachment, binding and removal of the phosphate. The phosphorylation of serine and threonine by kinases and the binding of pSer/pThr by phosphorylation-dependent scaffold proteins is largely determined by the sequence motif surrounding the phosphorylation site (p-site). The removal of the phosphate is regulated by pSer/pThr-specific phosphatases with the two most prominent ones being PP1 and PP2A. For this family, recent advances brought forward a more complex mechanism for p-site selection. The interaction of regulatory proteins with the substrate protein constitutes a first layer for substrate recognition, but also interactions of the catalytic subunit with the amino acids in close proximity to pSer/pThr contribute to p-site selection. Here, we review the current pieces of evidence for this multi-layered, complex mechanism and hypothesize that, depending on the degree of higher structure surrounding the substrate site, recognition is more strongly influenced by regulatory subunits away from the active site for structured substrate regions, whereas the motif context is of strong relevance with p-sites in disordered regions. The latter makes these amino acid sequences crossroads for signaling and motif strength between kinases, pSer/pThr-binding proteins and phosphatases.

Keywords: 14-3-3 proteins, intrinsically disordered proteins, protein phosphatases, protein-serine-threonine kinases, substrate recognition

Introduction

To react and adapt to changes, cells have developed more than 400 different post-translational modifications (PTMs), which act as dynamic modulators upon attachment to amino acid (AA) side chains in order to modify protein stability, activity, structure, localization and binding [1]. Among these, phosphorylation on the AAs serine (Ser) and threonine (Thr) is to date among the most frequently identified PTMs [1–3] and controls crucial cellular signaling events in processes such as learning, muscle contractility, growth, adaptation to stress, nutrient processing and immunity [4]. In multiple central signaling pathways aberrant phosphorylation on Ser/Thr represents a hallmark in the origin and manifestation of diseases and is therefore in the center of medicinal chemistry and drug development [5–7]. To provide the elementary understanding of signaling processes for future medical applications, a deep understanding of pSer/pThr regulation is therefore of central importance.

Advances in phosphoproteomics have led to a drastic increase in phosphorylation site (p-site) annotations over the last 15 years: Whereas at the beginning of the millennium the majority of the known phosphoproteome still consisted of p-sites identified and characterized by directed low-throughput (LTP) efforts aiming to study the role of single p-sites [8], this picture changed concomitant with the enormous speed of technological progress in subsequent years. This development is well reflected in a recent study by Beltrao and collaborators, combining knowledge of more than 6000 phosphoproteome experiments executed across human cell types. This holistic analysis of 112 human phosphoproteome datasets led to >119 000 phosphosites on ∼12 000 proteins (90 443 sites, when only considering high-confidence class I sites). These numbers therefore represent the to date most complete view on the human phosphoproteome [3].

Among all p-sites, pSer is observed significantly more often than pThr and pTyr: ∼5% constitute pThr, only 0.4–4% constitute pTyr sites, with pSer being by far more abundant [2]. When not only differentiating between classes of PTMs but also by AAs to which PTMs are attached to, pSer is therefore by far the most frequently observed PTM among all. Notably, these observations might also be influenced by methodological aspects, since PTMs vary in stability and detectability. However, despite having these large and precious datasets in hand, in-detail functional and regulatory characterization is lacking for the majority of these sites. Consequently, the increase in known p-sites currently does not lead to a linear increase in understanding of associated human diseases due to the lack of understanding of p-site regulation.

In this regard, many conclusions on pSer/pThr-sites were derived without considering the structural context surrounding pSer/pThr and the competing interplay between kinase, phosphatase and pSer/pThr-binding proteins. We see orthogonal insights into the regulation of the pSer/pThr phosphoproteome by the Phosphoprotein Phosphatases 1 and 2A (PP1, PP2A) that regulate the majority of pSer/pThr dephosphorylation events [9], as a current bottleneck for its interpretation. With this review we aim to highlight the necessity for an independent, structure-focused view on the human pSer/pThr phosphoproteome for a full understanding of its regulation by phosphoprotein phosphatases (PPPs).

Enzymes and interactors of the pSer/pThr phosphoproteome

Phosphorylation on pSer and pThr for modulation of protein function, structure, localization and activity is not regulatory by itself, but rather needs attachment and removal in a timely and specific manner in order to exhibit its full power in cellular signaling. The biggest advantage lies in the speed by which cells can change and adapt protein function upon signal input [10]. Whereas adapting to input by transcriptional or translational changes implies a rather long, multi-layer process, the modification of expressed proteins allows fast adaptation. Yet, an increase in pSer/pThr sites for adapting to more and more complex signaling events implies an equally complex toolbox of modifying enzymes in order to maintain the advances in pSer/pThr signaling cascades. For Ser/Thr-specific kinases, multiple gene duplications coincide with the growth of the functional phosphoproteome, leading to site-specific, motif-dependent Ser/Thr-phosphorylation. These motifs can range from acidic for Polo-like kinases (PLKs) [11,12] to basic, such as the R-R-x-S/T consensus in the PKA kinase motif or the often found consensus S/T-P-X-K for cyclin-dependent kinases (CDKs) [13].

pSer/pThr-binding protein domains, such as WW, forkhead-associated (FHA), and 14-3-3, have also been identified to add complexity to phosphosignaling by recruiting partner proteins and serving as signaling hubs in a phosphorylation-dependent manner. For 14-3-3 proteins, the Mode 1 (RSX(pS/T)XP) and Mode 2 (RX(F/Y)X(pS)XP) consensus motifs of 14-3-3 binding sites [14,15], mostly in disordered protein regions, have been identified [16–18]. Therefore, these proteins can be considered an additional layer for amplification of complex pSer/pThr signaling and the interplay with regulating kinases is well-established [15,17,19,20]. Several thousand 14-3-3 binding sites have been predicted in high-throughput approaches, but detailed characterization is lacking [21].

What has not entered the equation and the more holistic view of pSer/pThr signaling, are the counteracting phosphatases. This is mainly due to the fact that the picture is less clear for the most prominent family of pSer/pThr phosphatases, namely the PPPs. This subfamily of phosphatases consists of 7 phosphatases: PP1, PP2A, PP2B (Calcineurin), PP4, PP5, PP6 and PP7, with two of its best-studied members being Protein Phosphatase 1 and 2A (PP1, PP2A), on which this review focuses on. For most members of this set of phosphatases, evolution chose a different path than for kinases. PPPs mostly consist of a highly conserved catalytic core protein. This catalytic subunit (denoted for PP1 and PP2A here as PP1c and PP2Ac) does not show high degrees of flexibility, but rather provides rigid binding interfaces for the temporary docking of a multitude of substrate-specifying regulatory subunits [22]. These attach to the catalytic core protein in a combinatorial manner to form dimeric or even trimeric holoenzyme complexes in order to create specificity [9,23]. Similar to the catalytic subunits for kinases, the PPP regulatory subunits have been subjected to evolutionary diversification, leading to hundreds of different holoenzymes that specifically dephosphorylate certain pSer/pThr substrate sites [22].

Early findings of the 1980s and 1990s suggested that PP1c and PP2Ac exhibit an intrinsic specificity towards certain substrate motifs. These observations at the time were based either on sets of peptides synthesized in a targeted manner [24,25] or on functional read-outs of PP1/PP2A-regulated ion channels [26,27] and were already under dispute at the time [28]. Despite these pieces of evidence, the predominant opinion that was established over the following decades was that whereas kinases have intrinsic motif preference for AA surrounding pSer/pThr, PP1c and PP2Ac do not have substrate preferences around the active site. However, this picture for PP1and PP2A substrate specificity is incomplete, since recent advances in phosphatase research combined with the picture from proteomic approaches widen the process for p-site recognition to a contribution from the PP1c and PP2Ac subunit that favors certain motifs surrounding pSer/pThr, similar to the findings for the counteracting kinases: In the holoenzyme scenario the motif context surrounding pSer/pThr played a role for substrate selection [29–32], and also the preference of the complex of the PP2A catalytic subunit with its B55 regulatory subunit for pThr over pSer overlapped with early observations [32–35]. Our laboratory has recently provided evidence that the preferences for basic residues N-terminal of the p-site for PP1 and for pThr over pSer is caused by the catalytic subunit itself [36]. Consequently, not only the regulatory subunits create specificity, but also the surface in close vicinity of the catalytic cleft interacts with AAs N- and C-terminal of the p-site, thereby creating specificity on the motif-level, and also the catalytic cleft creates specificity for pThr over pSer in the cases of PP1c and PP2Ac [31,36–38]. Indeed, also for PP2B recent evidence shows a role of the active site in substrate recognition [39].

Intrinsically disordered regions as phosphorylation signaling hubs

In contrast to p-sites in ordered regions and Pfam domains, p-sites located within intrinsically disordered regions (IDRs) are located in sequence stretches and loop regions characterized by high flexibility that do not engage in stable secondary and tertiary conformations in their ground state. As a consequence, these IDRs are lacking structural features and binding interfaces that could potentially contribute to p-site selection for pSer/pThr-specific scaffold proteins, kinases, and phosphatases. Therefore, the p-site recognition in IDRs does not follow the classical thinking, in which secondary and tertiary protein structure determines the function of the protein region in a key/lock-like manner, also termed the function-follows-structure paradigm [40].

Given the two-layered system for p-site recognition by PP1 and PP2A holoenzymes introduced above, we hypothesize that these layers might contribute to p-site selection with varying degrees between structured and disordered regions. However, in the current literature there is a clear bias towards studying the regulatory impact of phosphorylation sites in ordered regions [41] due to two main factors: Firstly, residues in IDRs, due to their intrinsic flexibility, are often difficult to assign in structural biology methods, especially in crystallography, making it difficult to add structural insights to studies of these sites. Also, many cases are known for which an often unknown complex partner is needed in order to stabilize IDRs for structural studies [41]. Secondly, a large fraction of bioinformatic methods uses evolutionary sequence conservation in order to identify sites of regulatory importance. Yet, it has been clearly demonstrated in the case of cyclin-dependent kinase 1 (Cdk1) that despite their regulatory importance, p-sites in IDRs are more rapidly evolving and that the exact location of the p-site within IDRs is less relevant, making them more difficult to identify and study [42]. Due to the lower sequence conservation in IDRs, p-sites in these protein parts are less likely to be chosen for detailed follow-ups. Yet, studies from Iakoucheva et al. show the potential of studying p-sites in IDRs [43] and very recent work of Cho et al., in which they applied statistical thermodynamical approaches to understand the disordered phosphoproteome [44], clearly demonstrates the potential of analyzing kinase substrate sites in IDRs beyond considering solely kinase motif sequences.

To take an exemplary look at p-sites in long (≥31 AAs) IDRs [45,46] we analyzed phosphoproteomic datasets from our group [36] consisting of 1552 pSer/pThr sites. To this end, the full sequences of all corresponding proteins were retrieved from uniprot.org [47] and analyzed by DISOPRED3 [48], a reliable algorithm for identification of IDRs [49], using high-performance computing (HPC, Figure 1A). In our own dataset of 1552 p-sites, 939 (61%) of these were located in long IDRs [45,46], providing evidence that p-sites in IDRs are a common scenario in cellular signaling (Figure 1B). Further support that a distinct look on the IDR-located part of the phosphoproteome might lead to interesting insights comes from the observation that the phosphorylation state of an IDR seems to correlate with IDR length [50].

Figure 1. Analysis of a set of 1552 p-sites identified in Hoermann et al. [36] for structural properties.

Figure 1.

(A) Full length .fasta sequences of underlying phosphosites were retrieved from uniprot.org using the UniprotKB (accessed 11/12 2020) of the majority protein. IDRs were identified using the DISOPRED3 algorithm [48] (default settings, i.e. FDR 5%) on the bwUnicluster 2.0 high performance computing (HPC) resource of the state Baden-Wuerttemberg using batch scripts. The output .diso files were then further analyzed locally using python3 and R. (B) Information on p-site conformation was extracted from .diso DISOPRED3 output files, including +- 15 amino acids surrounding the p-site. Sites within 15 amino acids of the N- or C-terminus of the respective protein were included, inserting blank values for empty positions. A control dataset was generated by randomly selecting a 31 amino acid stretch on the same protein. A stringent definition for disordered regions was chosen: Only if all 30 amino acid residues surrounding the p-site were predicted to be disordered, a p-site region was considered disordered, otherwise these p-sites were assigned to the ordered category. This approach follows previous definitions for the identification of long IDRs [45,46]. The definition of PP1c or PP2Ac-sensitive sites follows the definition of Supplementary Data 2 in Hoermann et al. [36]. Statistics represent the p-value of a Fisher's exact test carried out in R. (C and D) The sequence motif within the categories depicted in Figure 2B were then further analyzed using iceLogo [78]. The sequence stretch submitted to motif analysis was limited to 10 AA N- and C-terminal of the p-site for better visualization and readability of motifs. The motifs were generated for a p-value of 0.05 and the amino acid labeling corresponds to the hydrophobicity at pH 7.0 with: blue = hydrophobic; red = neutral; green = acidic, charged; and yellow = basic, charged. (C) The motif comparison demonstrates the enrichment of amino acids S, P, R and K in the general amino acid distribution in IDRs. (D) Around p-sites in IDRs, R in position −3 and P in +1 are even further enriched.

Although IDRs themselves do not exclude the possibility that secondary and tertiary structure more distant from the p-site contribute to p-site selection, the intrinsic features of IDRs give the primary amino acid sequence in direct vicinity of pSer/pThr central importance and increased relevance for determining selectivity. The importance of p-sites in IDRs has been demonstrated in very recent proteomic approaches using thermal proteome profiling and pulse-chase-based phosphoproteomic experiments: In both cases the effect of phosphorylation on protein stability was largest with p-sites located in IDRs compared with structured regions, providing evidence that a large fraction of p-sites in IDRs serves a regulatory function [51,52]. Also for phosphatases, an enrichment of substrate sites in IDRs has been postulated, since most known substrate sites for phosphoprotein phosphatases PP1, PP2A, PP2B and PP2Cα are located in unstructured regions [53]. This trend is supported by the presented data for PP1, since despite being already enriched in IDRs, p-sites sensitive to PP1c are even more enriched in IDRs (Figure 1B).

While amino acid composition alone is not sufficient to identify and classify IDRs [54], work by Iakoucheva et al. and Basile et al. demonstrated that IDRs are enriched in the AAs Ser, Pro, Lys [55] and potentially Arg [43]. These findings are well supported by our own analysis, showing that in our dataset Ser, Pro, Arg and to some degree Lys are enriched by up to 15% in IDRs, whereas hydrophobic AAs are found more frequently in structured protein regions (Figure 1C). When looking at p-sites located within IDRs in our exemplary dataset, an even higher enrichment for Pro in +1, as well as for Arg in -3 is observed compared with the general AA distribution in IDRs. Therefore, these features can be considered p-site-specific (Figure 1D). Importantly, these enrichments also represent characteristic features of kinase- and 14-3-3-motifs introduced previously.

The role of IDRs in the context of PP1/PP2A holoenzymes and substrates

There is solid evidence for the importance of IDRs in interacting with the rigid catalytic core of PP1 and PP2A: For PP1, it has been demonstrated that more than 70% of its regulatory proteins constitute intrinsically disordered proteins (IDPs). For example, the complex of PP1 with its myosin-targeting subunit MYPT1 (PP1:MYPT1) [56], spinophilin [57], inhibitor 2 (I-2) [58] and Phosphatase 1 NUclear Targeting Subunit (PNUTS) [59–61], rely on disordered regions, termed short linear motifs (SLiMs) in order to interact with the catalytic subunit [62]. These (partially) disordered proteins adapt to the rigid PP1 catalytic core protein (PP1c), thereby following the paradigm that in most protein–protein interactions one binding partner provides a rigid template to which a second flexible partner protein adapts [62]. Interestingly, this rule also holds true in a reversed scenario for the interaction of PP1 with apoptosis stimulating protein of p53 (ASPP) for one of the only two disordered regions of PP1c, namely its C-terminal regulatory tail. The tail binds to the rigid SH3 domain of ASPP leading to its stabilization [63]. Similarly, for the complex of PP2A with its regulatory B56 subunit (PP2A:B56) an intrinsic preference of B56 to disordered regions in substrate proteins was found [29], for example within the B56 binding region of anaphase-promoting complex subunit 1(APC1) [64]. PP2A:B56 interacts with substrates by a SLiM consisting of an LxxIxE motif [29,65]. Also, the B55 subunit selects PP2A substrates by interaction with basic AAs in SLiMs around the p-site [66]. Therefore, despite the fact that in contrast to PP1 most regulatory B subunits of PP2A are rather structured, disordered regions are of great importance for substrate recruitment. Furthermore, very recent efforts allow to the widen angle and impact of this rational to other PPPs such as PP2B [67] and PP4 [68], which also use SLiM binding for substrate recognition making this a broad feature of the family.

It is therefore an intriguing idea to extend this paradigm to the regions on substrate proteins dephosphorylated by PP1c and PP2Ac: Since many of the PP1c and PP2Ac sensitive p-sites are located in IDRs lacking structural features for surface recognition, the primary amino acid context surrounding pSer/pThr gains special importance for interacting with the rigid grooves surrounding the catalytic cleft of these phosphatases. This places a layer of PPP specificity at the same level as motifs of kinase and pSer/pThr-binding proteins and makes these amino acid sequences crossroads for signaling and motif strength between enzyme classes. In fact, several cases are known for such a scenario: PP1/Repo-Man regulates the highly disordered N-terminus of Histone 3 (H3) [69,70] by dephosphorylating T3 [60] and S10 [71,72] to regulate mitosis, which in turn regulates the association of 14-3-3 proteins [73]. Similarly, the intrinsically disordered region around S455 of IRSp53 is a well-established substrate of the PP1/Phactr complex [74], which is also bound by 14-3-3 proteins [75]. Also, during entry into M-phase, CDC25C gets dephosphorylated by PP1 in its unstructured region around pS216 [76], again a site normally occupied by 14-3-3 proteins [77]. Indeed, we find in our own data that p-sites sensitive to PP1c and PP2Ac differ, depending on their structural characteristics: For PP1c, we find that the enrichment of Arg in −3 is only important in disordered regions, whereas position −1 plays a more important role in ordered domains (Figure 2A,B). For PP2Ac, we see that in general the impact of positive or negative charges is of higher relevance in the flexible loops of IDRs compared with structured regions (Figure 2C,D). In both cases this suggests that in flexible IDRs the impact of AA around the p-site is of higher relevance compared to p-sites in structured regions.

Figure 2. PP1c- and PP2Ac-sensitive sites display diverging motifs depending on their structural properties.

Figure 2.

(A) PP1c-sensitive sites are enriched for the often-found RxxpSP motif in IDRs. (B) The trend observed for PP1c in Figure 2A is not the case for ordered regions. In this scenario, the amino acid in −1 seems to be of higher importance compared with −3. (C) PP2Ac has a strong preference for acidic amino acids in disordered protein regions but disfavors basic residues R and K. (D) The trend observed for IDRs and PP2Ac in Figure 2C is not found in ordered regions. As for PP1c, the biggest effects are observed for the amino acid residues closest to the p-site.

Altogether, the following model of PP1/PP2A substrate specification has evolved: As a first layer for substrate targeting, PP1 and PP2A associate with regulatory subunits. This step can also lead to binding of a regulatory subunit close the catalytic subunits’ surface surrounding the catalytic cleft, which in turn alters the motif preference of the holoenyzme. The second layer of p-site selectivity is determined by the catalytic subunit and its surface properties as such and is actively contributing to the overall specificity of the holoenzyme [32]. These layers likely differ in strength and functionality depending on the regulatory subunit as well as the structural context of the p-site. Also, as recently demonstrated for kinase Ser-Pro (SP) motifs, mechanisms underlying the recognition of these p-sites are expected to involve thermodynamic factors, such as differences in free energy between phosphorylated/phosphorylated states [44]. Based on the above, we hypothesize that the second layer on the catalytic subunit level might be especially suited for binding IDRs and recognizing primary amino acid motifs around pSer/pThr, and might represent the main contribution for competing binding affinities between kinases, phosphatases and pSer/pThr-binding domains (Figure 3). This view is in good consent with models proposed by Rogers et al. that had not yet considered differences in amino acid distribution between IDRs and structured regions [38]. Based on recent findings regarding the substrate specificity of the catalytic subunits of PP1 and PP2A, we propose that the recognition of the AAs around the active site by the catalytic subunit could be a more important feature for PP1 than for PP2A.

Figure 3. Scheme displaying the potential impact of p-site structure on the dephosphorylation mechanism.

Figure 3.

According to this model, for PP1 and PP2A-sensitive p-sites located in IDRs, the amino acid sequence surrounding the p-site is important. The highly flexible region is able to align with the surface structures including grooves surrounding the catalytic cleft of PP1 and PP2A, giving the charges surrounding pSer/pThr higher importance compared with p-sites in ordered regions and adding a layer of p-site motif-dependent recognition and competition between phosphatases, kinases, and pSer/Thr binding proteins. In the latter case, active site recognition is less important and protein–protein interactions further away, for example between regulatory and catalytic subunit and the substrate protein, determine the substrate recognition.

Conclusion

The success in interpreting the exact role of more than 100 000 human p-sites in health and disease is largely dependent on deciphering a complex system between kinases, p-motif binding proteins and the multilayer specificity of phosphatases in the light of motif context and structural information. Given the recent insights presented in this review, we anticipate that disentangling the phosphoproteome in terms of sequence context and structural features will strongly help to elucidate the regulatory relevance of p-sites and the mechanism of p-site recognition by PP1 and PP2A in the upcoming years, and will support completing the understanding of the interplay between kinases, phosphatases, and interacting proteins with phosphoprotein p-sites.

Perspectives

  • Whilst data for the human phosphoproteome currently comprises more than 100 000 identified phosphorylation sites, only a small fraction has been studied in terms of regulation by kinases, phosphorylation-dependent binding proteins, and phosphatases.

  • The importance for the sequence context of substrate sites for Ser/Thr kinases and pSer/pThr-binding proteins is quite well established, however, a more complex model for the pSer/pThr phosphatases PP1 and PP2A is currently evolving.

  • For these phosphatases, further studies are needed to differentiate between substrate recognition by regulatory subunits distant from the pSer/pThr substrate site and motif recognition in direct vicinity of the pSer/pThr by the catalytic subunit. We hypothesize that these layers affect substrate recognition differently in structured and disordered protein regions.

Abbreviations

AA

amino acids

ASPP

apoptosis stimulating protein of p53

HPC

high-performance computing

IDRs

intrinsically disordered regions

PPPs

phosphoprotein phosphatases

PTMs

post-translational modifications

SLiMs

short linear motifs

Competing Interests

The authors declare that there are no competing interests associated with the manuscript.

Funding

This work was supported by the European Research Council with an ERC consolidator grant (#865119) to M.K., and by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG) under Germany's Excellence Strategy (BIOSS — EXC 294). The authors acknowledge support by the state of Baden-Württemberg through bwHPC.

Author Contributions

B.H. carried out the bioinformatic data analysis. B.H and M.K. wrote and edited the manuscript.

References

  • 1.Khoury, G.A., Baliban, R.C. and Floudas, C.A. (2011) Proteome-wide post-translational modification statistics: frequency analysis and curation of the Swiss-prot database. Sci. Rep. 1, srep00090 10.1038/srep00090 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Sharma, K., D'Souza, R.C.J., Tyanova, S., Schaab, C., Wiśniewski, J.R., Cox, J.et al. (2014) Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep. 8, 1583–1594 10.1016/j.celrep.2014.07.036 [DOI] [PubMed] [Google Scholar]
  • 3.Ochoa, D., Jarnuczak, A.F., Viéitez, C., Gehre, M., Soucheray, M., Mateus, A.et al. (2020) The functional landscape of the human phosphoproteome. Nat. Biotechnol. 38, 365–373 10.1038/s41587-019-0344-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ubersax, J.A., Ferrell, J.E. and Ferrell, Jr, J.E. (2007) Mechanisms of specificity in protein phosphorylation. Nat. Rev. Mol. Cell Biol. 8, 530–541 10.1038/nrm2203 [DOI] [PubMed] [Google Scholar]
  • 5.Zhang, J., Yang, P.L. and Gray, N.S. (2009) Targeting cancer with small molecule kinase inhibitors. Nat. Rev. Cancer. 9, 28–39 10.1038/nrc2559 [DOI] [PubMed] [Google Scholar]
  • 6.Ferguson, F.M. and Gray, N.S. (2018) Kinase inhibitors: the road ahead. Nat. Rev. Drug Discov. 17, 353–377 10.1038/nrd.2018.21 [DOI] [PubMed] [Google Scholar]
  • 7.Wu, P., Nielsen, T.E. and Clausen, M.H. (2015) FDA-approved small-molecule kinase inhibitors. Trends Pharmacol. Sci. 36, 422–439 10.1016/j.tips.2015.04.005 [DOI] [PubMed] [Google Scholar]
  • 8.Hornbeck P, V., Zhang, B., Murray, B., Kornhauser, J.M., Latham, V. and Skrzypek, E. (2015) Phosphositeplus, 2014: Mutations, PTMs and recalibrations. Nucleic Acids Res. 43, D512–D520 10.1093/nar/gku1267 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Bollen, M., Peti, W., Ragusa, M.J. and Beullens, M. (2010) The extended PP1 toolkit: Designed to create specificity. Trends Biochem. Sci. 35, 450–458 10.1016/j.tibs.2010.03.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Reddy, R.J., Gajadhar, A.S., Swenson, E.J., Rothenberg, D.A., Curran, T.G. and White, F.M. (2016) Early signaling dynamics of the epidermal growth factor receptor. Proc. Natl Acad. Sci. U.S.A. 113, 3114–3119 10.1073/pnas.1521288113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kettenbach, A.N., Wang, T., Faherty, B.K., Madden, D.R., Knapp, S., Bailey-Kellogg, C.et al. (2012) Rapid determination of multiple linear kinase substrate motifs by mass spectrometry. Chem. Biol. 19, 608–618 10.1016/j.chembiol.2012.04.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Kettenbach, A.N., Schweppe, D.K., Faherty, B.K., Pechenick, D., Pletnev, A.A. and Gerber, S.A. (2011) Quantitative phosphoproteomics identifies substrates and functional modules of aurora and polo-like kinase activities in mitotic cells. Sci. Signal. 4, rs5 10.1126/scisignal.2001497 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Pinna, L.A. and Ruzzene, M. (1996) How do protein kinases recognize their substrates? Biochim. Biophys. Acta Mol. Cell Res. 1314, 191–225 10.1016/S0167-4889(96)00083-3 [DOI] [PubMed] [Google Scholar]
  • 14.Yaffe, M.B. (2002) How do 14-3-3 proteins work? - Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett. 513, 53–57 10.1016/S0014-5793(01)03288-4 [DOI] [PubMed] [Google Scholar]
  • 15.Yaffe, M.B., Rittinger, K., Volinia, S., Caron, P.R., Aitken, A., Leffers, H.et al. (1997) The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 91, 961–971 10.1016/S0092-8674(00)80487-0 [DOI] [PubMed] [Google Scholar]
  • 16.Bustos, D.M. and Iglesias, A.A. (2006) Intrinsic disorder is a key characteristic in partners that bind 14-3-3 proteins. Proteins Struct. Funct. Bioinformatics 63, 35–42 10.1002/prot.20888 [DOI] [PubMed] [Google Scholar]
  • 17.Sluchanko, N.N. and Bustos, D.M. (2019) Intrinsic disorder associated with 14-3-3 proteins and their partners. Prog. Mol. Biol. Transl. Sci. 166, 19–61 10.1016/bs.pmbts.2019.03.007 [DOI] [PubMed] [Google Scholar]
  • 18.Bradley, D. and Beltrao, P. (2019) Evolution of protein kinase substrate recognition at the active site. PLoS Biol. 17, e3000341 10.1371/journal.pbio.3000341 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Mohammad, D.H. and Yaffe, M.B. (2009) 14-3-3 proteins, FHA domains and BRCT domains in the DNA damage response. DNA Repair (Amst) 8, 1009–1017 10.1016/j.dnarep.2009.04.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Yaffe, M.B. and Elia, A.E.H. (2001) Phosphoserine/threonine-binding domains. Curr. Opin. Cell Biol. 13, 131–138 10.1016/S0955-0674(00)00189-7 [DOI] [PubMed] [Google Scholar]
  • 21.Madeira, F., Tinti, M., Murugesan, G., Berrett, E., Stafford, M., Toth, R.et al. (2015) 14-3-3-Pred: improved methods to predict 14-3-3-binding phosphopeptides. Bioinformatics 31, 2276–2283 10.1093/bioinformatics/btv133 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Brautigan, D.L. and Shenolikar, S. (2018) Protein serine/threonine phosphatases: keys to unlocking regulators and substrates. Annu. Rev. Biochem. 87, 921–964 10.1146/annurev-biochem-062917-012332 [DOI] [PubMed] [Google Scholar]
  • 23.Hendrickx, A., Beullens, M., Ceulemans, H., Den Abt, T., Van Eynde, A., Nicolaescu, E.et al. (2009) Docking motif-guided mapping of the interactome of protein phosphatase-1. Chem. Biol. 16, 365–371 10.1016/j.chembiol.2009.02.012 [DOI] [PubMed] [Google Scholar]
  • 24.Agostinis, P., Goris, J., Pinna, L.A., Marchiori, F., Perich, J.W., Meyer, H.E.et al. (1990) Synthetic peptides as model substrates for the study of the specificity of the polycation-stimulated protein phosphatases. Eur. J. Biochem. 189, 235–241 10.1111/j.1432-1033.1990.tb15482.x [DOI] [PubMed] [Google Scholar]
  • 25.Pinna, L.A. and Donella-Deana, A. (1994) Phosphorylated synthetic peptides as tools for studying protein phosphatases. Biochim. Biophys. Acta Mol. Cell Res. 1222, 415–431 10.1016/0167-4889(94)90050-7 [DOI] [PubMed] [Google Scholar]
  • 26.Chung, S., Reinhart, P., Martin, B., Brautigan, D. and Levitan, I. (1991) Protein kinase activity closely associated with a reconstituted calcium-activated potassium channel. Science 253, 560–562 10.1126/science.1857986 [DOI] [PubMed] [Google Scholar]
  • 27.Reinhart, P.H., Chung, S., Martin, B.L., Brautigan, D.L. and Levitan, I.B. (1991) Modulation of calcium-activated potassium channels from rat brain by protein kinase A and phosphatase 2A. J. Neurosci. 11, 1627–1635 10.1523/JNEUROSCI.11-06-01627.1991 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Cohen, P. (1989) The structure and regulation of protein phosphatases. Annu. Rev. Biochem. 58, 453–508 10.1146/annurev.bi.58.070189.002321 [DOI] [PubMed] [Google Scholar]
  • 29.Hertz, E.P.T., Kruse, T., Davey, N.E., López-Méndez, B., Sigurðsson, J.O., Montoya, G.et al. (2016) A conserved motif provides binding specificity to the PP2A-B56 phosphatase. Mol. Cell. 63, 686–695 10.1016/j.molcel.2016.06.024 [DOI] [PubMed] [Google Scholar]
  • 30.Kauko, O., Imanishi, S.Y., Kulesskiy, E., Yetukuri, L., Laajala, T.D., Sharma, M.et al. (2020) Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1. J. Biol. Chem. 295, 4194–4211 10.1074/jbc.RA119.011265 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Kruse, T., Gnosa, S.P., Nasa, I., Garvanska, D.H., Hein, J.B., Nguyen, H.et al. (2020) Mechanisms of site-specific dephosphorylation and kinase opposition imposed by PP2A regulatory subunits. EMBO J. 39, e103695 10.15252/embj.2019103695 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Godfrey, M., Touati, S.A., Kataria, M., Jones, A., Snijders, A.P. and Uhlmann, F. (2017) PP2A cdc55 phosphatase imposes ordered cell-cycle phosphorylation by opposing threonine phosphorylation. Mol. Cell 65, 393–402.e3 10.1016/j.molcel.2016.12.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Rommel, C., Radziwill, G., Lovrić, J., Noeldeke, J., Heinicke, T., Jones, D.et al. (1996) Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1. Oncogene 12, 609–619 PMID: [PubMed] [Google Scholar]
  • 34.Touati, S.A., Hofbauer, L., Jones, A.W., Snijders, A.P., Kelly, G. and Uhlmann, F. (2019) Cdc14 and PP2A phosphatases cooperate to shape phosphoproteome dynamics during mitotic exit. Cell Rep. 29, 2105–2119.e4 10.1016/j.celrep.2019.10.041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Touati, S.A., Kataria, M., Jones, A.W., Snijders, A.P. and Uhlmann, F. (2018) Phosphoproteome dynamics during mitotic exit in budding yeast. EMBO J. 37, e98745 10.15252/embj.201798745 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Hoermann, B., Kokot, T., Helm, D., Heinzlmeir, S., Chojnacki, J.E., Schubert, T.et al. (2020) Dissecting the sequence determinants for dephosphorylation by the catalytic subunits of phosphatases PP1 and PP2A. Nat. Commun. 11, 3583 10.1038/s41467-020-17334-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.McCloy, R.A., Parker, B.L., Rogers, S., Chaudhuri, R., Gayevskiy, V., Hoffman, N.J.et al. (2015) Global phosphoproteomic mapping of early mitotic exit in human cells identifies novel substrate dephosphorylation motifs. Mol. Cell. Proteomics 14, 2194–2212 10.1074/mcp.M114.046938 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Rogers, S., McCloy, R., Watkins, D.N. and Burgess, A. (2016) Mechanisms regulating phosphatase specificity and the removal of individual phosphorylation sites during mitotic exit. BioEssays 38, S24–S32 10.1002/bies.201670905 [DOI] [PubMed] [Google Scholar]
  • 39.Hendus-Altenburger, R., Wang, X., Sjøgaard-Frich, L.M., Pedraz-Cuesta, E., Sheftic, S.R., Bendsøe, A.H.et al. (2019) Molecular basis for the binding and selective dephosphorylation of Na+/H+ exchanger 1 by calcineurin. Nat. Commun. 10, 3489 10.1038/s41467-019-11391-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Van Der Lee, R., Buljan, M., Lang, B., Weatheritt, R.J., Daughdrill, G.W., Dunker, A.K.et al. (2014) Classification of intrinsically disordered regions and proteins. Chem. Rev. 114, 6589–6631 10.1021/cr400525m [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Wright, P.E. and Dyson, H.J. (2015) Intrinsically disordered proteins in cellular signalling and regulation. Nat. Rev. Mol. Cell Biol. 16, 18–29 10.1038/nrm3920 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Holt, L.J., Tuch, B.B., Villen, J., Johnson, A.D., Gygi, S.P. and Morgan, D.O. (2009) Global analysis of Cdk1 substrate phosphorylation sites provides insights into evolution. Science 325, 1682–1686 10.1126/science.1172867 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Iakoucheva, L.M., Radivojac, P., Brown, C.J., O'Connor, T.R., Sikes, J.G., Obradovic, Z.et al. (2004) The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Res. 32, 1037–1049 10.1093/nar/gkh253 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Cho, M.-H., Wrabl, J.O., Taylor, J. and Hilser, V.J. (2020) Hidden dynamic signatures drive substrate selectivity in the disordered phosphoproteome. Proc. Natl Acad. Sci. U.S.A. 117, 23606–23616 10.1073/pnas.1921473117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Oates, M.E., Romero, P., Ishida, T., Ghalwash, M., Mizianty, M.J., Xue, B.et al. (2012) D2p2: database of disordered protein predictions. Nucleic Acids Res. 41, D508–D516 10.1093/nar/gks1226 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Oldfield, C.J. and Dunker, A.K. (2014) Intrinsically disordered proteins and intrinsically disordered protein regions. Annu. Rev. Biochem. 83, 553–584 10.1146/annurev-biochem-072711-164947 [DOI] [PubMed] [Google Scholar]
  • 47.Bateman, A. (2019) Uniprot: a worldwide hub of protein knowledge. Nucleic Acids Res. 47, D506–D515 10.1093/nar/gky1049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Jones, D.T. and Cozzetto, D. (2015) DISOPRED3: precise disordered region predictions with annotated protein-binding activity. Bioinformatics. 31, 857–863 10.1093/bioinformatics/btu744 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Nielsen, J.T. and Mulder, F.A.A. (2019) Quality and bias of protein disorder predictors. Sci. Rep. 9, 5137 10.1038/s41598-019-41644-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Koike, R., Amano, M., Kaibuchi, K. and Ota, M. (2020) Protein kinases phosphorylate long disordered regions in intrinsically disordered proteins. Protein Sci. 29, 564–571 10.1002/pro.3789 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Huang, J.X., Lee, G., Cavanaugh, K.E., Chang, J.W., Gardel, M.L. and Moellering, R.E. (2019) High throughput discovery of functional protein modifications by hotspot thermal profiling. Nat. Methods 16, 894–901 10.1038/s41592-019-0499-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Wu, C., Ba, Q., Lu, D., Li, W., Salovska, B., Hou, P.et al. (2021) Global and site-specific effect of phosphorylation on protein turnover. Dev. Cell 56, 111–124.e6 10.1016/j.devcel.2020.10.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Li, X., Wilmanns, M., Thornton, J. and Köhn, M. (2013) Elucidating human phosphatase-substrate networks. Sci. Signal. 6, rs10 10.1126/scisignal.6306er10 [DOI] [PubMed] [Google Scholar]
  • 54.Zarin, T., Strome, B., Nguyen Ba, A.N., Alberti, S., Forman-Kay, J.D. and Moses, A.M. (2019) Proteome-wide signatures of function in highly diverged intrinsically disordered regions. eLife 8, e46883 10.7554/eLife.46883 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Basile, W., Salvatore, M., Bassot, C. and Elofsson, A. (2019) Why do eukaryotic proteins contain more intrinsically disordered regions? PLoS Comput. Biol. 15, e1007186 10.1371/journal.pcbi.1007186 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Terrak, M., Kerff, F., Langseimo, K., Tao, T., Dominguez, R., Langsetmo, K.et al. (2004) Structural basis of protein phosphatase 1 regulation. Nature 429, 780–784 10.1038/nature02582 [DOI] [PubMed] [Google Scholar]
  • 57.Ragusa, M.J., Dancheck, B., Critton, D.A., Nairn, A.C., Page, R. and Peti, W. (2010) Spinophilin directs protein phosphatase 1 specificity by blocking substrate binding sites. Nat. Struct. Mol. Biol. 17, 459–464 10.1038/nsmb.1786 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Dancheck, B., Nairn, A.C. and Peti, W. (2008) Detailed structural characterization of unbound protein phosphatase 1 inhibitors. Biochemistry 47, 12346–12356 10.1021/bi801308y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Allen, P.B., Kwon, Y.-G., Nairn, A.C. and Greengard, P. (1998) Isolation and characterization of PNUTS, a putative protein phosphatase 1 nuclear targeting subunit. J. Biol. Chem. 273, 4089–4095 10.1074/jbc.273.7.4089 [DOI] [PubMed] [Google Scholar]
  • 60.Beullens, M., Van Eynde, A., Stalmans, W. and Bollen, M. (1992) The isolation of novel inhibitory polypeptides of protein phosphatase 1 from bovine thymus nuclei. J. Biol. Chem. 267, 16538–16544 10.1016/S0021-9258(18)42036-4 [DOI] [PubMed] [Google Scholar]
  • 61.Kreivi, J.P., Trinkle-Mulcahy, L., Lyon, C.E., Morrice, N.A., Cohen, P. and Lamond, A.I. (1997) Purification and characterisation of p99, a nuclear modulator of protein phosphatase 1 activity. FEBS Lett. 420, 57–62 10.1016/S0014-5793(97)01485-3 [DOI] [PubMed] [Google Scholar]
  • 62.Choy, M.S., Page, R. and Peti, W. (2012) Regulation of protein phosphatase 1 by intrinsically disordered proteins. Biochem. Soc. Trans. 40, 969–974 10.1042/BST20120094 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Bertran, M.T., Mouilleron, S., Zhou, Y., Bajaj, R., Uliana, F., Kumar, G.S.et al. (2019) ASPP proteins discriminate between PP1 catalytic subunits through their SH3 domain and the PP1 C-tail. Nat. Commun. 10, 771 10.1038/s41467-019-08686-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Fujimitsu, K. and Yamano, H. (2020) PP2A-B56 binds to Apc1 and promotes Cdc20 association with the APC/C ubiquitin ligase in mitosis. EMBO Rep. 21, e48503 10.15252/embr.201948503 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Wang, X., Bajaj, R., Bollen, M., Peti, W. and Page, R. (2016) Expanding the PP2A interactome by defining a B56-Specific SLiM. Structure 24, 2174–2181 10.1016/j.str.2016.09.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Cundell, M.J., Hutter, L.H., Nunes Bastos, R., Poser, E., Holder, J., Mohammed, S.et al. (2016) A PP2A-B55 recognition signal controls substrate dephosphorylation kinetics during mitotic exit. J. Cell Biol. 214, 539–554 10.1083/jcb.201606033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Wigington, C.P., Roy, J., Damle, N.P., Yadav, V.K., Blikstad, C., Resch, E.et al. (2020) Systematic discovery of short linear motifs decodes calcineurin phosphatase signaling. Mol. Cell 79, 342–358.e12 10.1016/j.molcel.2020.06.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Ueki, Y., Kruse, T., Weisser, M.B., Sundell, G.N., Larsen, M.S.Y., Mendez, B.L.et al. (2019) A consensus binding motif for the PP4 protein phosphatase. Mol. Cell 76, 953–964.e6 10.1016/j.molcel.2019.08.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Danilenko, N., Lercher, L., Kirkpatrick, J., Gabel, F., Codutti, L. and Carlomagno, T. (2019) Histone chaperone exploits intrinsic disorder to switch acetylation specificity. Nat. Commun. 10, 3435 10.1038/s41467-019-11410-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Zhang, L., Serra-Cardona, A., Zhou, H., Wang, M., Yang, N., Zhang, Z.et al. (2018) Multisite substrate recognition in Asf1-Dependent acetylation of histone H3 K56 by Rtt109. Cell. 174, 818–830.e11 10.1016/j.cell.2018.07.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Murnion, M.E., Adams, R.R., Callister, D.M., Allis, C.D., Earnshaw, W.C. and Swedlow, J.R. (2001) Chromatin-associated protein phosphatase 1 regulates aurora-B and histone H3 phosphorylation. J. Biol. Chem. 276, 26656–26665 10.1074/jbc.M102288200 [DOI] [PubMed] [Google Scholar]
  • 72.Karam, C.S., Kellner, W.A., Takenaka, N., Clemmons, A.W. and Corces, V.G. (2010) 14-3-3 mediates histone cross-Talk during transcription elongation in drosophila. PLoS Genet. 6, e1000975 10.1371/journal.pgen.1000975 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Winter, S., Simboeck, E., Fischle, W., Zupkovitz, G., Dohnal, I., Mechtler, K.et al. (2008) 14-3-3 proteins recognize a histone code at histone H3 and are required for transcriptional activation. EMBO J. 27, 88–99 10.1038/sj.emboj.7601954 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Fedoryshchak, R.O., Přechová, M., Butler, A.M., Lee, R., O'Reilly, N., Flynn, H.R.et al. (2020) Molecular basis for substrate specificity of the Phactr1/PP1 phosphatase holoenzyme. eLife 9, e61509 10.7554/eLife.61509 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Kast, D.J. and Dominguez, R. (2019) Mechanism of IRSp53 inhibition by 14-3-3. Nat. Commun. 10, 483 10.1038/s41467-019-08317-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Margolis, S.S., Walsh, S., Weiser, D.C., Yoshida, M., Shenolikar, S. and Kornbluth, S. (2003) PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation. EMBO J. 22, 5734–5745 10.1093/emboj/cdg545 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Gardino, A.K. and Yaffe, M.B. (2011) 14-3-3 proteins as signaling integration points for cell cycle control and apoptosis. Semin. Cell Dev. Biol. 22, 688–695 10.1016/j.semcdb.2011.09.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Colaert, N., Helsens, K., Martens, L., Vandekerckhove, J. and Gevaert, K. (2009) Improved visualization of protein consensus sequences by iceLogo. Nat. Methods 6, 786–787 10.1038/nmeth1109-786 [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Society Transactions are provided here courtesy of Portland Press Ltd

RESOURCES